Stem cell senescence and regenerative paradigms

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 1, 2012, Pages 21-29

  Beltrami, A P ^a   Cesselli, D ^a   Beltrami, C A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE DERIVED CELL; ATHEROSCLEROSIS; CARDIAC PROGENITOR CELL; CARDIOVASCULAR DISEASE; CELL REGENERATION; DIABETES MELLITUS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLIC SYNDROME X; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

ANIMALS; CARDIOVASCULAR DISEASES; CELL AGING; HUMANS; METABOLIC SYNDROME X; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84055169870     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.262     Document Type: Review

References (75)

1. Beltrami, A.P., Cesselli, D. & Beltrami, C.A. At the stem of youth and health. Pharmacol. Ther. 129, 3-20 (2011).
2. Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J. & Bartek, J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type-and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 10, 457-468 (2011).
3. Rota, M. et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ. Res. 99, 42-52 (2006). (Pubitemid 44297054)
4. Minamino, T. & Komuro, I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat. Clin. Pract. Cardiovasc. Med. 5, 637-648 (2008).
5. Dimmeler, S. & Leri, A. Aging and disease as modifiers of efficacy of cell therapy. Circ. Res. 102, 1319-1330 (2008).
6. Cesselli, D. et al. Effects of age and heart failure on human cardiac stem cell function. Am. J. Pathol. 179, 349-366 (2011).
7. Bays, H.E. Adiposopathy is "sick fat" a cardiovascular disease? J. Am. Coll. Cardiol. 57, 2461-2473 (2011).
8. Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M. & Kirkland, J.L. Aging and regional differences in fat cell progenitors-a mini-review. Gerontology 57, 66-75 (2011).
9. Hicks, G.E. et al. Trunk muscle composition as a predictor of reduced functional capacity in the health, aging and body composition study: the moderating role of back pain. J. Gerontol. A Biol. Sci. Med. Sci. 60, 1420-1424 (2005). (Pubitemid 41798449)
10. Y amamoto, Y., Gesta, S., Lee, K.Y., Tran, T.T., Saadatirad, P. & Kahn, C.R. Adipose depots possess unique developmental gene signatures. Obesity (Silver Spring). 18, 872-878 (2010).
11. Ibrahim, M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 11, 11-18 (2010).
12. Heilbronn, L., Smith, S.R. & Ravussin, E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 28 (suppl. 4), S12-S21 (2004). (Pubitemid 40143844)
13. El-Ftesi, S., Chang, E.I., Longaker, M.T. & Gurtner, G.C. Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plast. Reconstr. Surg. 123, 475-485 (2009).
14. Oikawa, A. et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler. Thromb. Vasc. Biol. 30, 498-508 (2010).
15. O'Rourke, M.F., Safar, M.E. & Dzau, V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc. Med. 15, 461-468 (2010).
16. Y oder, M.C. Is endothelium the origin of endothelial progenitor cells? Arterioscler. Thromb. Vasc. Biol. 30, 1094-1103 (2010).
17. Chang, E. & Harley, C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. U.S.A. 92, 11190-11194 (1995).
18. Fadini, G.P. & Avogaro, A. Cell-based methods for ex vivo evaluation of human endothelial biology. Cardiovasc. Res. 87, 12-21 (2010).
19. Campagnolo, P., Wong, M.M. & Xu, Q. Progenitor cells in arteriosclerosis: good or bad guys? Antioxid. Redox Signal. 15, 1013-1027 (2011).
20. Burton, D.G., Matsubara, H. & Ikeda, K. Pathophysiology of vascular calcification: Pivotal role of cellular senescence in vascular smooth muscle cells. Exp. Gerontol. 45, 819-824 (2010).
21. Beltrami, A., Cesselli, D. & Beltrami, C. Multiple sources for cardiac stem cells and their cardiogenic potential. In: Regenerating the Heart (eds. Cohen, I.S. & Gaudette, G.R.) 149-171 (Humana Press, New York, 2011).
22. A huja, P., Sdek, P. & MacLellan, W.R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544 (2007). (Pubitemid 47086282)
23. Chimenti, C. et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 93, 604-613 (2003). (Pubitemid 37222156)
24. Urbanek, K. et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA 102, 8692-8697 (2005). (Pubitemid 40862797)
25. De Angelis, A. et al. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121, 276-292 (2010).
26. Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001). (Pubitemid 32290358)
27. Kawamoto, A. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637 (2001). (Pubitemid 32144189)
28. Laflamme, M.A. & Murry, C.E. Heart regeneration. Nature 473, 326-335 (2011).
29. A ssmus, B. et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232 (2006).
30. Makino, S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705 (1999). (Pubitemid 29122423)
31. Mirotsou, M., Jayawardena, T.M., Schmeckpeper, J., Gnecchi, M. & Dzau, V.J. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell. Cardiol. 50, 280-289 (2011).
32. Tendera, M. et al.; REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur. Heart J. 30, 1313-1321 (2009).
33. Beltrami, A.P. et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (2003). (Pubitemid 37186770)
34. Messina, E. et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-921 (2004). (Pubitemid 39435006)
35. Gimble, J.M., Katz, A.J. & Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249-1260 (2007). (Pubitemid 46742916)
36. Cao, Y., Sun, Z., Liao, L., Meng, Y., Han, Q. & Zhao, R.C. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 332, 370-379 (2005). (Pubitemid 40724988)
37. Léobon, B. et al. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc. Res. 83, 757-767 (2009).
38. Beltrami, A.P., Cesselli, D. & Beltrami, C.A. Pluripotency rush! Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells. Pharmacol. Ther. 124, 23-30 (2009).
39. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41 (2009).
40. Mauritz, C. et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517 (2008).
41. Martinez-Fernandez, A., Nelson, T.J., Ikeda, Y. & Terzic, A. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. J. Cardiovasc. Transl. Res. 3, 13-23 (2010).
42. Nelson, T.J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y. & Terzic, A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416 (2009).
43. Pera, M.F. Stem cells: The dark side of induced pluripotency. Nature 471, 46-47 (2011).
44. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
45. Hofmann, M. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111, 2198-2202 (2005). (Pubitemid 40632435)
46. Loffredo, F.S., Steinhauser, M.L., Gannon, J. & Lee, R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8, 389-398 (2011).
47. Tang, X.L. et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121, 293-305 (2010).
48. Efimenko, A., Starostina, E., Kalinina, N. & Stolzing, A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J. Transl. Med. 9, 10 (2011).
49. Cramer, C. et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev. 19, 1875-1884 (2010).
50. Ronnebaum, S.M. & Patterson, C. The FoxO family in cardiac function and dysfunction. Annu. Rev. Physiol. 72, 81-94 (2010).
51. Bhaskar, P.T. & Hay, N. The two TORCs and Akt. Dev. Cell 12, 487-502 (2007).
52. Kim, J., Kundu, M., Viollet, B. & Guan, K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141 (2011).
53. Okoshi, R. et al. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem. 283, 3979-3987 (2008).
54. Farsetti, A., Grasselli, A., Bacchetti, S., Gaetano, C. & Capogrossi, M.C. The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling. J. Appl. Physiol. 106, 333-337 (2009).
55. Rahman, S. & Islam, R. Mammalian Sirt1: insights on its biological functions. Cell Commun. Signal 9, 11 (2011).
56. Palacios, J.A., Herranz, D., De Bonis, M.L., Velasco, S., Serrano, M. & Blasco, M.A. SIRT1 contributes to telomere maintenance and augments global homologous recombination. J. Cell Biol. 191, 1299-1313 (2010).
57. Lee, I.H. et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 105, 3374-3379 (2008).
58. Freund, A., Patil, C.K. & Campisi, J. p38MAPK is a novel DNA damage responseindependent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536-1548 (2011).
59. Hong, E.H. et al. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J. Biol. Chem. 285, 1283-1295 (2010).
60. D'Amario, D. et al. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ. Res. 108, 1467-1481 (2011).
61. Blagosklonny, M.V. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Cell Cycle 9, 4788-4794 (2010).
62. Petrovski, G., Gurusamy, N. & Das, D.K. Resveratrol in cardiovascular health and disease. Ann. N. Y. Acad. Sci. 1215, 22-33 (2011).
63. Ramot, Y. et al. Spermidine promotes human hair growth and is a novel modulator of human epithelial stem cell functions. PLoS ONE 6, e22564 (2011).
64. A nisimov, V.N. et al. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany. NY). 3, 148-157 (2011).
65. Chen, L.L., Liao, Y.F., Zeng, T.S., Yu, F., Li, H.Q. & Feng, Y. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine 38, 266-275 (2010).
66. Sorrentino, S.A. et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptorgamma agonist rosiglitazone. Circulation 116, 163-173 (2007). (Pubitemid 47057522)
67. Bruedigam, C. et al. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 28, 916-927 (2010).
68. Csiszar, A. et al. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell 6, 783-797 (2007). (Pubitemid 350131047)
69. Spallotta, F. et al. Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemia. Stem Cells 28, 431-442 (2010).
70. Ito, K. et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12, 446-451 (2006).
71. Spallarossa, P. et al. p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells. PLoS ONE 5, e15583 (2010).
72. Shi, Y., Do, J.T., Desponts, C., Hahm, H.S., Schöler, H.R. & Ding, S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525-528 (2008). (Pubitemid 351729222)
73. Y ang, C.S., Lopez, C.G. & Rana, T.M. Discovery of nonsteroidal antiinflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells 29, 1528-1536 (2011).
74. Chen, T. et al. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 10, 908-911 (2011).
75. Gorospe, M. & Abdelmohsen, K. MicroRegulators come of age in senescence. Trends Genet. 27, 233-241 (2011).